ONCOCYTE CORP (OCX) Stock Cash Flow
NASDAQ:OCX - Nasdaq - US68235C2061 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -43.14M | -27.78M | -72.90M | -64.10M | -29.93M | |||
| Depreciation Amortization | 1.32M | 1.68M | 5.22M | 4.20M | 390.00K | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | -9.26M | -1.25M | |||
| Change In Working Capital | -673.00K | -3.97M | -1.94M | -2.20M | 400.00K | |||
| Interest Paid | 17.00K | 0.00 | 20.00K | 110.00K | 210.00K | |||
| Other non cash items | 22.57M | 6.75M | 24.06M | 35.42M | 4.41M | |||
| OPERATING CASH FLOW | -19.92M | -23.32M | -45.57M | -35.94M | -25.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -563.00K | -281.00K | -4.34M | -2.25M | -1.23M | |||
| Other Investing Activity | N/A | -651.00K | 0.00 | -11.71M | -10.52M | |||
| INVESTING CASH FLOW | -64.00K | -932.00K | -4.34M | -13.96M | -11.75M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -146.00K | -117.00K | -1.43M | -1.53M | 700.00K | |||
| Stock Issued/Repurchased | N/A | 12.73M | 37.72M | 82.96M | 22.24M | |||
| Other Financing Activity | N/A | -427.00K | -480.00K | -3.07M | -130.00K | |||
| FINANCING CASH FLOW | 9.56M | 12.19M | 35.81M | 78.36M | 22.80M | |||
| CHANGE IN CASH | -10.43M | -12.07M | -14.10M | 28.46M | -14.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.92M | -23.32M | -45.57M | -35.94M | -25.98M | |||
| Capital Expenditure | -563.00K | -281.00K | -4.34M | -2.25M | -1.23M | |||
| FREE CASH FLOW | -20.49M | -23.61M | -49.91M | -38.19M | -27.21M | |||
All data in USD